AI platform aiding clinical experts in cancer research. Uses OCR and NLP to extract structured data from medical records for trial matching and real-world evidence. $65.4M funded.
Vendor description
AI-powered clinical data extraction and trial matching
Clinical data extraction,Trial matching with NLP/OCR,Real-world evidence from EHR
- AI-powered OCR and NLP
- Clinical data extraction
- $65.4M funded
- Real-world evidence capabilities
- Primarily oncology focus
- Data extraction focused,not full platform
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | North America |
| Service model | SaaS |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Small,Medium,Large |
| Therapeutic areas | Oncology, Rare diseases, Cardiovascular, Immunology |
Related vendors
Editorial ranking
See how Mendel.ai compares - best AI / Machine Learning vendors for clinical trials.